prednisone has been researched along with terbinafine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gupta, AK; Porges, AJ | 1 |
| Hearne, D; Knight, D; Magro, CM; Schaefer, JT; Seilstad, K; Waldman, J | 1 |
| Gunawardane, N; Ibrahimi, OA; Reynolds, RV; Sepehr, A | 1 |
| Grooters, A; Knorr, J; Oldenhoff, W; Pinkerton, ME; Trepanier, L | 1 |
| Khurana, R; Sonthalia, S | 1 |
| Baran, W; Hryncewicz-Gwózdz, A; Jagielski, T; Maj, J; Wojciechowska-Zdrojowy, M | 1 |
| Dai, YQ; Liu, ZH; Shen, H; Zhang, Y; Zhu, J | 1 |
| Hsu, S; Mollanazar, NK; Motaparthi, K; Ross, CL; Shevchenko, A | 1 |
| da Costa Nery, JA; Pereira Cardozo, MR; Tavares Rodrigues, F | 1 |
| Della Maggiore, A; Grooters, AM; Marks, SL; Pesavento, PA; Reagan, KL; Zhu, BY | 1 |
2 review(s) available for prednisone and terbinafine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Acute generalized exanthematous pustulosis due to terbinafine.
Topics: Acute Generalized Exanthematous Pustulosis; Antifungal Agents; Biopsy; Female; Glucocorticoids; Humans; Middle Aged; Prednisone; Remission Induction; Skin; Terbinafine; Treatment Outcome | 2018 |
12 other study(ies) available for prednisone and terbinafine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hypersensitivity syndrome reaction to oral terbinafine.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Fever; Foot Dermatoses; Glucocorticoids; Humans; Lymphatic Diseases; Male; Naphthalenes; Onychomycosis; Prednisone; Syndrome; Terbinafine | 1998 |
Terbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositis.
Topics: Antifungal Agents; Blotting, Western; Complement Membrane Attack Complex; Dermatomyositis; Endothelium, Vascular; Fluorescent Antibody Technique, Direct; Glucocorticoids; Humans; Male; Middle Aged; Muscle Weakness; Naphthalenes; Prednisone; Terbinafine; Withholding Treatment | 2008 |
Terbinafine-induced acute generalized exanthematous pustulosis (AGEP) responsive to high dose intravenous corticosteroid.
Topics: Acute Generalized Exanthematous Pustulosis; Anti-Inflammatory Agents; Antifungal Agents; Clobetasol; Diphenhydramine; Fatigue; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Methylprednisolone; Middle Aged; Naphthalenes; Onychomycosis; Pain; Prednisone; Terbinafine | 2009 |
Cutaneous pythiosis in two dogs from Wisconsin, USA.
Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Dog Diseases; Dogs; Female; Immunotherapy; Itraconazole; Male; Molecular Sequence Data; Naphthalenes; Prednisone; Pythiosis; Pythium; RNA, Ribosomal; Terbinafine; Wisconsin | 2014 |
Kerion.
Topics: Administration, Oral; Antifungal Agents; Child; Cicatrix; Diagnosis, Differential; Glucocorticoids; Humans; Male; Naphthalenes; Prednisone; Pyoderma; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2016 |
Paradoxical Reaction During a Course of Terbinafine Treatment of Trichophyton interdigitale Infection in a Child.
Topics: Child; Drug Eruptions; Humans; Long-Term Care; Naphthalenes; Prednisone; Retreatment; Terbinafine; Tinea | 2016 |
Successful treatment of severe kerion Celsi in an immunocompromised girl with evacuation of pus, terbinafine and short course glucocorticosteroids.
Topics: Abscess; Antifungal Agents; Child; Drainage; Female; Glucocorticoids; Hair; Humans; Immunocompromised Host; Naphthalenes; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Suppuration; Terbinafine; Tinea Capitis; Trichophyton | 2016 |
Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
Topics: Antifungal Agents; Brazil; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Prednisone; Recurrence; Rifampin; Terbinafine; Thalidomide; Tinea; Trichophyton; Young Adult | 2018 |
Successful management of 3 dogs with colonic pythiosis using itraconzaole, terbinafine, and prednisone.
Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Colon; Dog Diseases; Dogs; Gastrointestinal Diseases; Itraconazole; Prednisone; Pythiosis; Pythium; Serologic Tests; Terbinafine | 2019 |